BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21821544)

  • 21. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinomas of an unknown primary origin--diagnosis and treatment.
    Massard C; Loriot Y; Fizazi K
    Nat Rev Clin Oncol; 2011 Nov; 8(12):701-10. PubMed ID: 22048624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M; Rutqvist LE; Johansson H
    Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of the diagnostic methods in head and neck cancer of unknown primary site.
    Aro K; Bäck L; Mäkitie A; Tapiovaara L
    Acta Otolaryngol; 2018 Oct; 138(10):930-936. PubMed ID: 30016889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific survival rates for cancer of unknown primary according to location of metastases.
    Hemminki K; Riihimäki M; Sundquist K; Hemminki A
    Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
    Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
    Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
    Varadhachary GR; Raber MN; Matamoros A; Abbruzzese JL
    Lancet Oncol; 2008 Jun; 9(6):596-9. PubMed ID: 18510991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensive diagnostic work-up for patients with carcinoma of unknown primary.
    Meijer L; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP; Loef C
    Clin Exp Metastasis; 2021 Apr; 38(2):231-238. PubMed ID: 33515369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
    Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer.
    Economopoulou P; Mountzios G; Pavlidis N; Pentheroudakis G
    Cancer Treat Rev; 2015 Jul; 41(7):598-604. PubMed ID: 26033502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metastases of unknown origin--principles of diagnosis and treatment].
    Petrović D; Muzikravić L; Jovanović D
    Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective Cohort of Referrals to a Cancer of Unknown Primary Clinic, including Direct Access from Primary Care.
    Creak A
    Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):e87-e92. PubMed ID: 31635979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site.
    Sato J; Shimoi T; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Fujiwara Y; Yoshida M; Tamura K
    Intern Med; 2019 May; 58(10):1423-1428. PubMed ID: 30713301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathological diagnostics of CUP (Cancer of Unknown Primary)].
    Tímár J
    Magy Onkol; 2019 Jun; 63(2):67-74. PubMed ID: 31225529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer of unknown primary: time trends in incidence, United States.
    Mnatsakanyan E; Tung WC; Caine B; Smith-Gagen J
    Cancer Causes Control; 2014 Jun; 25(6):747-57. PubMed ID: 24710663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radiological diagnostics in CUP syndrome].
    Kazmierczak PM; Nikolaou K; Rominger A; Graser A; Reiser MF; Cyran CC
    Radiologe; 2014 Feb; 54(2):117-23. PubMed ID: 24500247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.